These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5469433)

  • 1. Treatment of obesity in the Bantu: value of a low-carbohydrate diet with and without an appetite suppressant.
    Kew MC
    S Afr Med J; 1970 Sep; 44(35):1006-7. PubMed ID: 5469433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of various appetite depressants under controlled conditions].
    Kreze A; Toman A
    Bratisl Lek Listy; 1973; 59(4):406-12. PubMed ID: 4751882
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chlorphentermine in the treatment of obesity].
    Chjnowski JR; Adamska-Dyniewska H; Leszczyński B; Mockallo T
    Pol Tyg Lek; 1968 Sep; 23(40):1531-3. PubMed ID: 5725611
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with a Hungarian-made chlorphentermine-type anorexigenig preparation (Desopimon) in the treatment of hypothalamopathies].
    Takács L; Pethö B
    Orv Hetil; 1969 Mar; 110(10):540-2. PubMed ID: 5779971
    [No Abstract]   [Full Text] [Related]  

  • 5. [Patterns of glucose and pyruvate curves during treatment of obesity with chlorphentermine (Avipron)].
    Adamska-Dyniewska H; Kowalczyk L
    Wiad Lek; 1968 Nov; 21(21):1901-4. PubMed ID: 5714921
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-lipaemic effect of Desopimon in obesity and in diabetes mellitus accompanied by obesity.
    Less E
    Ther Hung; 1974; 22(1):27-31. PubMed ID: 4844928
    [No Abstract]   [Full Text] [Related]  

  • 7. Desopimon in the management of obesity associated with heart disease.
    Gonda F; Kenedi I
    Ther Hung; 1973; 21(2):82-4. PubMed ID: 4792883
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the action of concentrated lucofen with prolonged effect].
    Godefroy G; Napolier A; Andriambao-Damasy S
    Mars Med; 1968; 105(3):289-93. PubMed ID: 5739899
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment of obesity in coronary disease patients].
    Villela AA; Magalhães A; Leszek G
    Hospital (Rio J); 1966 Sep; 70(3):571-84. PubMed ID: 5300270
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxic and therapeutic effects of EMTP in obesity.
    Hollingsworth DR; Amatruda TT
    Clin Pharmacol Ther; 1969; 10(4):540-2. PubMed ID: 4893585
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of chlorphentermine (Desopimon) on fat metabolism.
    Krámer M; Kenedi I; Gonda F
    Ther Hung; 1973; 21(2):77-8. PubMed ID: 4792881
    [No Abstract]   [Full Text] [Related]  

  • 12. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of phentermine-amphetamine resin complex with sustained-release dextroamphetamine and placebo in the treatment of exogenous obesity.
    De Felice EA; Cohen A; Schmitz PL; Rothwell KG; Truant AP
    J Clin Pharmacol J New Drugs; 1968; 8(6):360-9. PubMed ID: 4883784
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind trial of anorectic agents.
    Sproule BC
    Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of obesity: some recent concepts.
    Weinhaus RS
    Mo Med; 1969 Sep; 66(9):719-23 passim. PubMed ID: 4897933
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
    Liebermeister H; Probst G; Jahnke K
    Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
    [No Abstract]   [Full Text] [Related]  

  • 17. TDrug therapy in obesity.
    Ruedy J
    Mod Treat; 1967 Nov; 4(6):1138-45. PubMed ID: 6080141
    [No Abstract]   [Full Text] [Related]  

  • 18. CHLORPHENTERMINE S.A. IN THE TREATMENT OF OBESITY AND THE EFFECT OF WEIGHT LOSS ON STEROID EXCRETION.
    JACKSON IM; WHYTE WG
    Br Med J; 1965 Aug; 2(5459):453-5. PubMed ID: 14314911
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypotensive effect of fenfluramine in the treatment of obesity.
    Practitioner; 1971 Jul; 207(237):101-5. PubMed ID: 5557039
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hunger control with benzphetamine hydrochloride in the treatment of obesity].
    Linquette A; Fossati P
    Lille Med; 1971 Apr; 16():Suppl 2:620-4. PubMed ID: 5162097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.